ANAVEX LIFE SCIENCES CORP. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Anavex Life Sciences Corp. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q3 2024.
  • Anavex Life Sciences Corp. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 84.8M shares, a 3.33% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 84.8M +2.73M +3.33% Sep 30, 2024 10-K 2024-12-23
Q2 2024 84.8M +3.4M +4.18% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 83.6M +3.38M +4.21% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 82.1M +4.05M +5.2% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 82.1M +4.12M +5.29% Sep 30, 2023 10-K 2024-12-23
Q2 2023 81.4M +3.45M +4.42% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 80.2M +3.07M +3.98% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 78M +1.88M +2.47% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 77.9M +2.02M +2.67% Sep 30, 2022 10-K 2023-11-27
Q2 2022 77.9M +2.79M +3.72% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 77.2M +7.13M +10.2% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 76.2M +9.19M +13.7% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 75.9M +13.9M +22.4% Sep 30, 2021 10-K 2022-11-28
Q2 2021 75.1M +15.1M +25.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 70M +11.4M +19.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 67M +9.88M +17.3% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 62M +9.39M +17.8% Sep 30, 2020 10-K 2021-11-24
Q2 2020 60.1M +8.57M +16.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 58.7M +10.5M +21.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 57.1M +10.2M +21.7% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 52.7M +6.72M +14.6% Sep 30, 2019 10-K 2020-12-28
Q2 2019 51.5M +6.2M +13.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 48.2M +3.6M +8.08% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 46.9M +2.47M +5.55% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 45.9M +2.6M +6.01% Sep 30, 2018 10-K 2019-12-16
Q2 2018 45.3M +3.14M +7.45% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 44.6M +3.2M +7.73% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 44.4M +3.75M +9.23% Dec 31, 2017 10-Q 2018-02-07
Q3 2017 43.3M +7.16M +19.8% Sep 30, 2017 10-K/A 2019-01-25
Q2 2017 42.2M +6.46M +18.1% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 41.4M +5.68M +15.9% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 40.7M +6.01M +17.4% Dec 31, 2016 10-Q 2017-02-07
Q3 2016 36.2M +4.12M +12.9% Sep 30, 2016 10-K 2017-12-11
Q2 2016 35.7M -50.5M -58.6% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 35.7M -29.2M -45% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 34.7M -20.2M -36.8% Dec 31, 2015 10-Q 2016-02-08
Q3 2015 32M +20.2M +172% Sep 30, 2015 10-K 2016-12-14
Q2 2015 86.2M +48M +125% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 64.9M +26.6M +69.6% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 54.8M +17.2M +45.6% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 11.8M -25.4M -68.3% Sep 30, 2014 10-K 2015-12-29
Q2 2014 38.3M +8.02M +26.5% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 38.3M +8.02M +26.5% Mar 31, 2014 10-Q/A 2014-05-30
Q4 2013 37.6M +7.4M +24.5% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 37.2M +7M +23.1% Sep 30, 2013 10-K 2014-12-29
Q2 2013 30.2M +75K +0.25% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 30.2M +2.78M +10.1% Mar 31, 2013 10-Q 2013-05-17
Q4 2012 30.2M +3.05M +11.2% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 30.2M +3.67M +13.8% Sep 30, 2012 10-K 2013-12-30
Q2 2012 30.2M +4.24M +16.4% Jun 30, 2012 10-Q 2012-08-17
Q1 2012 27.5M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 27.2M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 26.6M +3.05M +13% Sep 30, 2011 10-K 2012-12-31
Q2 2011 25.9M Jun 30, 2011 10-Q 2011-08-12
Q3 2010 23.5M Sep 30, 2010 10-K 2011-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.